MUM-1

The MUM1 (Multiple Myeloma Oncogene 1) test is an immunohistochemistry (IHC) test used to detect MUM1 protein expression in tissue samples. It is mainly used in diagnosing lymphomas and plasma cell neoplasms.

This test helps classify different types of lymphomas, such as diffuse large B-cell lymphoma (DLBCL), multiple myeloma, and other hematological malignancies. It assists in determining disease prognosis and guiding treatment.

A biopsy sample is taken from lymph nodes or bone marrow and processed for immunohistochemical staining. A pathologist examines the stained tissue under a microscope to assess MUM1 protein expression.

Positive staining for MUM1 suggests certain types of B-cell lymphomas or multiple myeloma. It helps differentiate aggressive lymphomas from indolent ones, influencing treatment strategies.

If MUM1 expression is detected, further molecular tests or imaging may be needed. Treatment options could include chemotherapy, targeted therapy, or immunotherapy, depending on the type and stage of lymphoma.